Ledger.Open graph →

SEC Form D · filed October 27, 2009

Tarsa Therapeutics, Inc

Offering

$24.1M

Sold

$12.1M

Exemption

—

Industry

Biotechnology

Location

BOSTON, MA

Type

—

People & firms on this filing (4)

David Brand · Boston, MAExec · Director Eric Bednarski · Boston, MADirector David Brand · Philadelphia, PAExec · Director Eric Bednarski · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗

Tarsa Therapeutics, Inc. — SEC Form D filing (2009) | Ledger